SCHEMBL29928740

SCHEMBL29928740

CCOCc1cccc(COCCO)c1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.46
MRGPRX4 Q96LA9 3/20 0.36
CYP4F2 P78329 2/20 0.36
CYP4A11 Q02928 2/20 0.36
TP53 P04637 1/20 0.36
PKM P14618 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
TSHR P16473 1/20 0.35
IDO1 P14902 2/20 0.35
CHRM3 P20309 1/20 0.34
NAAA Q02083 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20548123 1.00 ALDH1A1 (0.46) ALDH1A1MRGPRX4CYP4F2CYP4A11TP53
SCHEMBL20485056 0.90 TSHR (0.42) ALDH1A1MRGPRX4CYP4F2CYP4A11TSHR
SCHEMBL21657589 0.89 CTSD (0.38) ALDH1A1SMN1; SMN2TSHRIDO1
SCHEMBL649159 0.86 TSHR (0.46) MRGPRX4TP53PKMNFKB1NFKB2
SCHEMBL21169086 0.86 KDM4E (0.39) ALDH1A1CYP4F2CYP4A11SMN1; SMN2TSHR
SCHEMBL29928701 0.85 MRGPRX4 (0.46) MRGPRX4CYP4F2CYP4A11TP53PKM
SCHEMBL20547932 0.85 MRGPRX4 (0.46) MRGPRX4CYP4F2CYP4A11TP53PKM
SCHEMBL19889624 0.82 TSHR (0.47) ALDH1A1CYP4F2CYP4A11SMN1; SMN2TSHR
SCHEMBL29200252 0.82 CYP4F2 (0.55) CYP4F2CYP4A11
SCHEMBL30771521 0.82 CYP4F2 (0.55) CYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112638477-B Pyrrolo [2,3-B ] pyridine derivatives as inhibitors of influenza virus replication 共晶制药公司 2024-01-26 CN disclosed
CN-110637022-B Pyrrolopyrimidine derivatives as inhibitors of influenza virus replication 共晶制药公司 2022-09-16 CN disclosed